1. Trisenox induces cytotoxicity through phosphorylation of mitogen‐activated protein kinase molecules in acute leukemia cells
    Sanjay Kumar et al, 2018, Journal of Biochemical and Molecular Toxicology CrossRef
  2. Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p–MFF axis
    Song Fan et al, 2015, Oncotarget CrossRef
  3. The Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma
    Piotr Cierpikowski et al, 2023, Cells CrossRef
  4. Disruption of Mitotic Progression by Arsenic
    J. Christopher States, 2015, Biological Trace Element Research CrossRef
  5. The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma
    Yali Cheng et al, 2021, Frontiers in Oncology CrossRef
  6. Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells
    Toshiki Nakaoka et al, 2014, Cellular Oncology CrossRef
  7. miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1
    Song Fan et al, 2015, Cancer Letters CrossRef
  8. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells
    Sherien M. El-Daly et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  9. Combination of arsenic trioxide and chemotherapy in small cell lung cancer
    Chun-yan Zheng et al, 2013, Lung Cancer CrossRef
  10. Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer
    Meenakshi Upreti et al, 2106, Oncotarget CrossRef
  11. Molecular mechanisms of cisplatin cytotoxicity in acute promyelocytic leukemia cells
    Sanjay Kumar et al, 2015, Oncotarget CrossRef
  12. Autophagy Interplays with Apoptosis and Cell Cycle Regulation in the Growth Inhibiting Effect of Trisenox in HEP-2, a Laryngeal Squamous Cancer
    Débora Lima Pereira et al, 2015, Pathology & Oncology Research CrossRef
  13. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance
    Alak Manna et al, 2015, Phytomedicine CrossRef
  14. Computational studies, design and synthesis of Pd(II)-based complexes: Allosteric inhibitors of the Human Topoisomerase-IIα
    Fillipe V. Rocha et al, 2019, Journal of Inorganic Biochemistry CrossRef
  15. p53 as a unique target of action of cisplatin in acute leukaemia cells
    Sanjay Kumar et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
  16. Combinatorial Low Dose Arsenic Trioxide and Cisplatin Exacerbates Autophagy via AMPK/STAT3 Signaling on Targeting Head and Neck Cancer Initiating Cells
    Wei-Chun Hu et al, 2020, Frontiers in Oncology CrossRef
  17. Arsenic Trioxide Triggers Apoptosis of Metastatic Oral Squamous Cells Carcinoma with Concomitant Downregulation of GLI1 in Hedgehog Signaling
    Raphael Luís Rocha Nogueira et al, 2022, Biomedicines CrossRef
  18. miR-183 Modulates Cell Apoptosis and Proliferation in Tongue Squamous Cell Carcinoma SCC25 Cell Line
    Dayong Yan et al, 2016, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
  19. Beyond cisplatin: Combination therapy with arsenic trioxide
    Ðenana Miodragović et al, 2019, Inorganica Chimica Acta CrossRef
  20. Mechanistic update of Trisenox in blood cancer
    null Ananta et al, 2023, Current Research in Pharmacology and Drug Discovery CrossRef
  21. Oral Administration of Clinical Stage Drug Candidate SENS-401 Effectively Reduces Cisplatin-induced Hearing Loss in Rats
    Mathieu Petremann et al, 2017, Otology & Neurotology CrossRef